Patents by Inventor John F. Connaughton

John F. Connaughton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8524877
    Abstract: The present invention provides oligonucleotide probes and oligonucleotide probe collections for detecting or localizing a plurality nucleic acid target genes within a cell or tissue sample. Specifically, the invention provides collections of oligonucleotide probes for use in in situ hybridization analyses in which each probe has a label-domain with the sequence formulas of (CTATTTT)nCT, (AAAATAG)n or (TTTTATC)n or (GATAAAA)n in which all cases “n” would equal 1 or greater. The present invention also provides collections or “cocktails” of oligonucleotide probes for detecting or localizing specific nucleic acid target genes within a cell or tissue sample.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: September 3, 2013
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Joseph G. Utermohlen, John F. Connaughton
  • Publication number: 20120309951
    Abstract: The present invention provides oligonucleotide probes and oligonucleotide probe collections for detecting or localizing a plurality nucleic acid target genes within a cell or tissue sample. Specifically, the invention provides collections of oligonucleotide probes for use in in situ hybridization analyses in which each probe has a label-domain with the sequence formulas of (CTATTTT)nCT, (AAAATAG)n or (TTTTATC)n or (GATAAAA)n in which all cases “n” would equal 1 or greater. The present invention also provides collections or “cocktails” of oligonucleotide probes for detecting or localizing specific nucleic acid target genes within a cell or tissue sample.
    Type: Application
    Filed: June 28, 2012
    Publication date: December 6, 2012
    Inventors: Joseph G. Utermohlen, John F. Connaughton
  • Patent number: 8236502
    Abstract: The present invention provides oligonucleotide probes and oligonucleotide probe collections and protein labeling for detecting or localizing a plurality nucleic acid target genes or antigens within a cell or tissue sample. Specifically, the invention provides collections of oligonucleotide probes for use in in situ hybridization analyses in which each probe has a label-domain with the sequence formulas of (CTATTTT)nCT, (AAAATAG)n or (TTTTATC)n or (GATAAAA)n in which all cases “n” would equal 1 or greater. The present invention provides collections or “cocktails” of oligonucleotide probes for detecting or localizing specific nucleic acid target genes within a cell or tissue sample.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: August 7, 2012
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Joseph G. Utermohlen, John F. Connaughton
  • Publication number: 20110034682
    Abstract: The present invention provides oligonucleotide probes and oligonucleotide probe collections and protein labeling for detecting or localizing a plurality nucleic acid target genes or antigens within a cell or tissue sample. Specifically, the invention provides collections of oligonucleotide probes for use in in situ hybridization analyses in which each probe has a label-domain with the sequence formulas of (CTATTTT)nCT, (AAAATAG)n or (TTTTATC)n or (GATAAAA)n in which all cases “n” would equal 1 or greater. The present invention provides collections or “cocktails” of oligonucleotide probes for detecting or localizing specific nucleic acid target genes within a cell or tissue sample.
    Type: Application
    Filed: October 22, 2010
    Publication date: February 10, 2011
    Inventors: Joseph G. Utermohlen, John F. Connaughton
  • Patent number: 7838655
    Abstract: The present invention provides oligonucleotide probes and oligonucleotide probe collections and protein labeling for detecting or localizing a plurality nucleic acid target genes or antigens within a cell or tissue sample. Specifically, the invention provides collections of oligonucleotide probes for use in in situ hybridization analyses in which each probe has a label-domain with the sequence formulas of (CTATTTT)nCT, (AAAATAG)n or (TTTTATC)n or (GATAAAA)n in which all cases “n” would equal 1 or greater. The present invention provides collections or “cocktails” of oligonucleotide probes for detecting or localizing specific nucleic acid target genes within a cell or tissue sample.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: November 23, 2010
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Joseph G. Utermohlen, John F. Connaughton
  • Patent number: 7250254
    Abstract: A method of detecting reciprocal gene translocations by employing multiple probe sets which span the breakpoint regions and encompass regions on both sides of each breakpoint of the translocation on each chromosome involved in the translocation. Probe sets and diagnostic kits for the method are also disclosed.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: July 31, 2007
    Assignee: Ventana Medical Systems, Inc
    Inventors: Jeanne Dietz-Band, Wang-Ting Hsieh, John F. Connaughton
  • Publication number: 20040014088
    Abstract: The present invention provides oligonucleotide probes and oligonucleotide probe collections and protein labeling for detecting or localizing a plurality nucleic acid target genes or antigens within a cell or tissue sample. Specifically, the provides collections of oligonucleotide probe for use in in situ hybridization analyses in which each probe has a label-domain with the sequence formulas of (CTATTTT)n, (AAAATAG)n or (TTTTATC)n or (GATAAAA)n in which all cases “n” would equal 1 or greater. The present invention provides collections or “cocktails” of oligonucleotide probes for detecting or localizing specific nucleic acid target genes within a cell or tissue sample.
    Type: Application
    Filed: July 21, 2003
    Publication date: January 22, 2004
    Inventors: Joseph G. Utermohlen, John F. Connaughton
  • Publication number: 20020182628
    Abstract: A method of detecting reciprocal gene translocations by employing multiple probe sets which span the breakpoint regions and encompass regions on both sides of each breakpoint of the translocation on each chromosome involved in the translocation. Probe sets and diagnostic kits for the method are also disclosed.
    Type: Application
    Filed: April 8, 2002
    Publication date: December 5, 2002
    Applicant: Ventana Medical Systems, Inc.
    Inventors: Jeanne Dietz-Band, Wang-Ting Hsieh, John F. Connaughton
  • Patent number: 6414133
    Abstract: The invention is directed to a DNA probe set, the probe set comprising a first probe set and a second probe set, the first probe set being sufficient in length and substantially complementary to an entire breakpoint region of a first DNA and nucleotides breakpoint region but less than an entire chromosome such that the first probe set will hybridize to both sides of the breakpoint region regardless of whether the first DNA has been broken in the breakpoint region and either end fused to another DNA, and the second probe set being sufficient in length and substantially complementary to an entire breakpoint region of a second DNA and nucleotides on both sides of the breakpoint region but less than an entire chromosome such that the second probe set will hybridize to both sides of the breakpoint region regardless of whether the second DNA has been broken in the breakpoint region and either end fused to another DNA. Diagnostic kits utilizing the probe sets of the invention are also claimed.
    Type: Grant
    Filed: October 13, 1998
    Date of Patent: July 2, 2002
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Jeanne Dietz-Band, Wang-Ting Hsieh, John F. Connaughton
  • Patent number: 5451519
    Abstract: The present invention relates to a method for cloning genes that encode restriction endonucleases by altering the level of a methyl donor co-factor of a DNA methyltransferase that protects the DNA of a host cell from damage by a restriction endonuclease. The method can be used to screen entire DNA libraries en masse to identify clones that encode restriction enzymes by growing one library replicate under high or normal methyl donor conditions to protect host DNA and a second library replicate under low methyl donor conditions allowing DNA damage from the active restriction endonuclease. Clones that encode a restriction enzyme are identified by decreased growth or color produced in response to double stranded DNA damage under the low methyl donor conditions. Colorimetric methods useful in the invention can use SOS-sensitive promoters operably linked to .beta.-galactosidase, which detect DNA damage.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: September 19, 1995
    Assignee: Georgetown University
    Inventors: Gordon B. Collier, John F. Connaughton, Jack G. Chirikjian